Sep 13, 2022 7:00am EDT ProMIS Neurosciences appoints accomplished biopharmaceutical leader, Dr. Gail M. Farfel, as Chief Executive Officer
Aug 15, 2022 5:00pm EDT ProMIS Neurosciences Announces Second Quarter 2022 Financial and Operating Results